Alx Oncology Holdings Inc (NASDAQ: ALXO) is -90.06% lower on its value in year-to-date trading and has touched a low of $1.19 and a high of $17.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALXO stock was last observed hovering at around $1.84 in the last trading session, with the day’s loss setting it -0.36%.
Currently trading at $1.48, the stock is -5.07% and -0.62% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.72 million and changing -19.57% at the moment leaves the stock -77.14% off its SMA200. ALXO registered -89.42% loss for a year compared to 6-month loss of -77.44%. The firm has a 50-day simple moving average (SMA 50) of $1.4921 and a 200-day simple moving average (SMA200) of $6.53925.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 20.33% gain in the last 1 month and extending the period to 3 months gives it a -28.50%, and is 4.23% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.34% over the week and 12.23% over the month.
Alx Oncology Holdings Inc (ALXO) has around 72 employees, a market worth around $78.06M and $0.00M in sales. Distance from 52-week low is 24.37% and -91.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-99.25%).
The EPS is expected to grow by 26.31% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
142.0 institutions hold shares in Alx Oncology Holdings Inc (ALXO), with institutional investors hold 89.98% of the company’s shares. The shares outstanding are 52.74M, and float is at 34.33M with Short Float at 20.89%. Institutions hold 88.21% of the Float.
The top institutional shareholder in the company is VENBIO PARTNERS LLC with over 9.7 million shares valued at $58.49 million. The investor’s holdings represent 19.3531 of the ALXO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 7.81 million shares valued at $47.12 million to account for 15.5923 of the shares outstanding. The other top investors are VIVO CAPITAL, LLC which holds 4.22 million shares representing 8.4198 and valued at over $25.45 million, while REDMILE GROUP, LLC holds 8.0535 of the shares totaling 4.04 million with a market value of $24.34 million.
Alx Oncology Holdings Inc (ALXO) Insider Activity
The most recent transaction is an insider purchase by Hemrajani Rekha, the company’s Director. SEC filings show that Hemrajani Rekha bought 30,000 shares of the company’s common stock on Dec 02 ’24 at a price of $1.55 per share for a total of $46404.0. Following the purchase, the insider now owns 33000.0 shares.
Alx Oncology Holdings Inc disclosed in a document filed with the SEC on Aug 14 ’24 that Pinto Shelly (SVP, FINANCE AND CAO) sold a total of 564 shares of the company’s common stock. The trade occurred on Aug 14 ’24 and was made at $2.58 per share for $1455.0. Following the transaction, the insider now directly holds 91549.0 shares of the ALXO stock.
Still, SEC filings show that on Aug 14 ’24, Randolph Sophia (CHIEF MEDICAL OFFICER) disposed off 1,365 shares at an average price of $2.58 for $3522.0. The insider now directly holds 325,711 shares of Alx Oncology Holdings Inc (ALXO).
